CN109970814A - Pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline and preparation method thereof - Google Patents

Pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline and preparation method thereof Download PDF

Info

Publication number
CN109970814A
CN109970814A CN201910323217.9A CN201910323217A CN109970814A CN 109970814 A CN109970814 A CN 109970814A CN 201910323217 A CN201910323217 A CN 201910323217A CN 109970814 A CN109970814 A CN 109970814A
Authority
CN
China
Prior art keywords
pyridine
asymmetric
nnn
bipyridyl
imidazoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910323217.9A
Other languages
Chinese (zh)
Inventor
郝新奇
祝智慧
王艳冰
王小蝶
王梦玲
赵雪梅
朱新举
宋毛平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhengzhou University
Original Assignee
Zhengzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhengzhou University filed Critical Zhengzhou University
Priority to CN201910323217.9A priority Critical patent/CN109970814A/en
Publication of CN109970814A publication Critical patent/CN109970814A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046Ruthenium compounds
    • C07F15/0053Ruthenium compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses pincerlike ruthenium compounds of one kind asymmetric NNN ' containing pyridine-pyridine-imidazoline and preparation method thereof, and general formula is as follows:, wherein R1For C1‑C15Alkyl, aryl, R2For aryl.The synthetic method of such pincerlike ruthenium compound is: by 2,2- bipyridyl by hydrogen peroxide oxidation, itrile group hydrolyzes and obtains 2,2- bipyridyl -6- carboxylic acid, and for 2,2- bipyridyl -6- carboxylic acids using chloro, amination, then chloro, cyclization obtains ligand, ligand and RuCl2(PPh3)3The pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline is obtained in reflux in toluene.The present invention provides a kind of with 2,2- bipyridyl cheap and easy to get for starting material, synthesizes easy, the easy method of asymmetric pincerlike ruthenium compound.

Description

Pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline and preparation method thereof
Technical field
The invention belongs to metal-organic synthesis and applied technical field, it is related to non-containing pyridine-pyridine-imidazoline Pincerlike ruthenium compound of symmetrical NNN ' and preparation method thereof.
Background technique
Pincerlike metallic compound is composed of tridentate ligand and metal center, by adjusting the substitution on pincer ligand Group, the space structure and cloud density of adjustable complex.In numerous coordinating groups, imidazoline, which has, to be easy to repair The features such as decorations, stable structure, thus get the attention.By the difference of chiral amino alcohol in synthesis process, formation has The imidazoline ring of different structure to adjust the three-dimensional effect of ligand, and then influences its activity in catalysis reaction.Previous Research in, there are many synthesis about pincerlike compound, including symmetric form and asymmetrical type, symmetric form include NCN type, PCP type, CCC type, asymmetrical type include PCN type, CCN type, PNN type etc..Pincerlike metallic compound is due to its unique three teeth knot Structure makes it have unique property, such compound has been widely used in organic synthesis, luminescent material, supermolecule at present The multiple fields such as chemistry, molecular recognition are especially rapidly developed in the application of catalytic field in recent years.
By in consideration of it, present invention design has synthesized a kind of novel asymmetric NNN ' type pincer ruthenium compound.
Summary of the invention
Technical problem to be solved by the invention is to provide pincerlike ruthenium compound of a kind of asymmetric NNN ' and preparation method thereof, By adjusting R1, R2Substituent group on group, thus it is possible to vary the electronic effect and three-dimensional effect of complex, thus modulating compound Activity in catalysis reaction.
In order to solve the above technical problems, the invention adopts the following technical scheme:
The pincerlike ruthenium compound of one kind asymmetric NNN ' containing pyridine-pyridine-imidazoline, general structure are as follows:
,
Wherein R1For C1-C15Alkyl, aryl, R2For aryl.
The preparation method is as follows: the pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline synthesizes by the following method: With cheap 2,2'- bipyridyl for starting material, 2,2'- bipyridyls react generation 2 with hydrogen peroxide in trifluoroacetic acid solution, 2 '-bipyridyl -1- oxides, then, 2,2 '-bipyridyl -1- oxides and trimethyl nitrile silane, chlorobenzoyl chloride are in anhydrous dichloro It is reacted in methane and obtains within 4 days 2,2 '-bipyridyl -6- formonitrile HCNs, hydrolysis occurs in alkali and obtains 2,2- for 2,2 '-bipyridyl -6- formonitrile HCNs 2,2- bipyridyl -6- carboxylic acid is flowed back in thionyl chloride, steams thionyl chloride, anhydrous dichloromethane is added by bipyridyl -6- carboxylic acid Alkane dissolution, it is anti-in room temperature after being added dropwise then in the anhydrous methylene chloride solution that condition of ice bath is added dropwise to chiral amino alcohol It should stay overnight, then be spin-dried for reaction solution, continue to flow back in thionyl chloride, after reflux, steam thionyl chloride, be added anhydrous Methylene chloride dissolution, is equally added dropwise in the anhydrous methylene chloride solution of aromatic amine, after being added dropwise, in room under condition of ice bath Temperature reaction overnight, is then added 10% sodium hydrate aqueous solution, extracts, dry, concentration, and thin-layer chromatography is isolated asymmetric NNN ' pincer ligand.By NNN ' pincer ligand and RuCl2(PPh3)3In reflux in toluene, atropurpureus solid is precipitated, it is as non-right Claim the pincerlike ruthenium compound of NNN '.
Specific steps are as follows:
(1) 2,2- bipyridyl is passed through into hydrogen peroxide oxidation, itrile group, hydrolysis obtains 2,2- bipyridyl -6- carboxylic acid;
(2) 2,2- bipyridyl -6- carboxylic acid is flowed back in thionyl chloride, then boils off excessive thionyl chloride, ice bath instills hand Property amino alcohol anhydrous methylene chloride solution in, after being added dropwise, reaction overnight, be then spin-dried for obtaining amide compound;
(3) thionyl chloride is added into amide compound and continues back flow reaction, then boil off excessive thionyl chloride, be added anhydrous Methylene chloride and triethylamine, then aromatic amine is added dropwise in ice bath, is stirred overnight at room temperature, is eventually adding the aqueous solution of sodium hydroxide, after It is continuous to be stirred overnight, it extracts, dry, concentration, thin-layer chromatography obtains asymmetric pincer ligand;
(4) asymmetric pincer ligand and RuCl2(PPh3)3It reacts in reflux in toluene, cools down after reaction, be directly precipitated solid Body is washed with ether to get target compound is arrived.
Further, the molar ratio of 2,2- bipyridyl -6- carboxylic acid and thionyl chloride is 1:(7-21 in the step (2)), 2, 2- bipyridyl -6- carboxylic acid back flow reaction 8-12h in thionyl chloride, 2, the 2- bipyridyl -6- carboxylic acid and chiral amino alcohol Molar ratio is 1:(1-2).
Further, the molar ratio of amide compound and aromatic amine is 1:(1-2 in the step (3)).
Further, amide compound return time in thionyl chloride is 8-12h in the step (3).
Further, the molar ratio of amide compound and thionyl chloride is 1:(7-21 in the step (3)), amide compound Molar ratio with triethylamine, sodium hydroxide is 1:6:(8-12).
Further, room temperature is stirred to react 8-16h after the pure and mild aromatic amine of chiral amino is added dropwise in ice bath.
Further, the aqueous solution of sodium hydroxide is added in the step (3), continues to be stirred to react 8-12h, sodium hydroxide The mass concentration of aqueous solution is 10%.
Further, in the step (4), asymmetric pincer ligand and RuCl2(PPh3)3The ratio between the amount of substance be 1:(1- 2), reflux time is 2-5 hours.
Beneficial effects of the present invention: the present invention relates to the pincerlike ruthenium chemical combination of one kind asymmetric NNN ' containing pyridine-pyridine-imidazoline The synthesis of object, such compound and traditional rhodium, the metallic compounds such as palladium are compared, relatively inexpensively, meanwhile, with oxazoline It closes object to compare, other substituent groups can be introduced on NR group, change the electronic effect and three-dimensional effect of complex with this, from And activity of the modulating compound in catalysis reaction.
Specific embodiment
Combined with specific embodiments below, the present invention will be further described.It should be understood that following embodiment is merely to illustrate this The person skilled in the art of the range of invention and is not intended to limit the present invention, the field can make one according to the content of foregoing invention A little nonessential modifications and adaptations.
Embodiment one
The preparation of 2,2'- bipyridyl -6- carboxylic acid: -6 formonitrile HCN of 2,2 '-bipyridyl (1.0 g, 5.5 mmol) and sodium hydroxide (0.85 g, 21 mmol) one hour of back flow reaction in the mixed solution of alcohol-water (10 mL:10 mL), solution are cooling Concentrated hydrochloric acid is added afterwards and is acidified to pH=3.8 or so, has white solid precipitation, then filters, wash solid with ice water, place into Vacuum oven drying is to get to 2,2- bipyridyl -6- carboxylic acid.Yield: 0.92 g, 83%;Fusing point: 133-134oC.1H NMR (400 MHz, d 6 -DMSO) δ 13.29 (s, 1H), 8.72 (d, J = 5.0 Hz, 1H), 8.59 (dd, J = 7.6, 1.3 Hz, 1H), 8.55 (d, J = 7.9 Hz, 1H), 8.17-8.08 (m, 2H), 8.00 (ddd, J = 7.6, 7.6, 1.8 Hz, 1H), 7.51 (ddd, J = 7.6, 4.8, 1.3 Hz, 1H); 13C{1H} NMR (100 MHz, d 6 -DMSO) δ 166.0, 155.2, 154.5, 149.3, 148.0, 138.7, 137.4, 124.8, 124.6, 123.5, 121.1. IR(KBr pellets, cm−1): 3436, 3372, 3058, 1698, 1615, 1583, 1534, 1471, 1754, 1259, 1169, 765, 713. HRMS (ESI-TOF) m/z: [M + H]+ calcd for C11H9N2O2 201.0659, found 201.0660.
Embodiment two
RuCl2(PPh3)3Preparation: by 1gRuCl3·3H2O is added in 150 mL methanol, and flow back 5min, is added after cooling 6.029 gPPh3, continue the 3h that flows back, stops reaction, it is cooling, by glossiness crystallization is precipitated in hot solution, filters, crystallization is used Ether washing is dried afterwards for several times.Brown solid, yield 83.7%, fusing point: 145-146oC。1H NMR (400MHz, CDCl3) δ 7.71-7.63 (dd, J = 12.0, 7.5 Hz, 6H), 7.58-7.51 (dd, J = 7.5, 7.5 Hz, 3H), 7.50-7.42 (m, 6H). 13C{1H} NMR (100 MHz, CDCl3) δ 133.1, 132.2, 132.1, 131.9, 128.6,128.5.31P{1H} NMR (162 MHz,CDCl3) δ 29.0 (s, PPh3), IR (cm-1): 3049, 1480, 1432, 1086, 741, 691, 514, 495。
Embodiment three
The pincerlike ruthenium compound containing the asymmetric NNN ' of pyridine-pyridine-imidazoline of the present embodiment the preparation method is as follows:
(1) (S) -6- (4- (tert-butyl) -1- (p-methylphenyl) -4,5- dihydro -1HImidazoles -2- base) -2,2'- bipyridyl system Standby: 2,2- bipyridyl -6- carboxylic acids (10mmol) back flow reaction 8h in thionyl chloride solution (5 mL), revolving remove excessive Asia Chlorosulfuric acid give light yellow oil is dissolved in anhydrous methylene chloride solution, under condition of ice bath, is added dropwise into dissolved with L- (11mmol, 1.29 g) and in the anhydrous methylene chloride solution of triethylamine (30mmol, 4.2 mL), are added dropwise tertiary leucinol Afterwards, reaction is stayed overnight at room temperature.After reaction, reactant is spin-dried for, ethyl acetate is added, is filtered to remove insoluble matter, filtrate It is continuously added after being spin-dried for and reacts 8h under thionyl chloride (5 mL) reflux state, revolving removes excessive thionyl chloride and obtains rufous oil Shape object is dissolved in anhydrous methylene chloride solution, under condition of ice bath, be added dropwise into dissolved with para-totuidine (11mmol, 1.2 g) and in the anhydrous methylene chloride solution of triethylamine (60 mmol, 8 mL), after being stirred overnight at room temperature, add 10% hydrogen Aqueous solution of sodium oxide (35 mL), room temperature continue to stir 8-12h, after, liquid separation, water phase is extracted with dichloromethane 3 times, merges Organic phase is added anhydrous magnesium sulfate drying, filters, be spin-dried for, column chromatography for separation (eluant, eluent ratio PE/EA=3/1 ~ 1/10) To corresponding NNN ' ligand.Brown solid;Yield: 52%;Fusing point: 119-121oC。1H NMR (400 MHz, CDCl3) δ 8.57 (d, J = 4.7 Hz, 1H), 8.33 (d, J = 7.7 Hz, 1H), 7.99 (d, J = 7.7, Hz, 1H), 7.84 (t, J = 7.7 Hz, 1H), 7.53 (ddd, J = 7.7, 7.7, 1.8 Hz, 1H), 7.37 (d,J = 8.0 Hz, 1H), 7.19 (ddd, J = 7.5, 4.8, 1.2 Hz, 1H), 6.99 (d, J = 8.0 Hz, 2H), 6.80 (d, J = 8.0 Hz, 2H), 4.23-4.13 (m, 1H), 4.10-4.01 (m, 1H), 3.71 (t,J = 8.4 Hz, 1H), 2.26 (s, 3H), 1.03 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3) δ 160.3, 155.7, 154.8, 149.4, 148.8, 141.6, 137.5, 136.5, 133.3, 129.1, 124.1, 123.7, 123.5, 121.4, 121.3, 74.2, 55.6, 34.3, 26.0, 20.8. IR(cm-1): 2949, 2860, 1592, 1560, 1515, 1463, 1432, 1388, 1362, 1161, 1144, 992, 821, 786, 750, 564. HRMS (ESI-TOF) m/z: [M + H]+calcd for C24H27N4 371.2230, found 371.2238.
(2) (S) -6- (4- (tert-butyl) -1- (p-methylphenyl) -4,5- dihydro -1HImidazoles -2- base) -2,2'- bipyridyl triphen The preparation of base phosphine dichloride ruthenium: be added in the Shrek bottle equipped with 100 mL for being stirred at reflux device (S) -6- (4- (tertiary fourth Base) -1- (p-methylphenyl) -4,5- dihydro -1HImidazoles -2- base) -2,2'- bipyridyl (0.4mmol, 148mg), three (triphenyls Phosphine) ruthenous chloride (0.4mmol, 383mg) and 30 mL toluene, back flow reaction 3h, after reaction, cooling under a nitrogen atmosphere Solid is precipitated, filters, is washed with ether to get product (170 mg) is arrived.Yield 53%.Violet solid, fusing point: > 300oC。1H NMR (600 MHz, CDCl3) δ 9.55-9.45 (m, 1H), 7.74 (d, J = 7.9 Hz, 1H), 7.63 (d,J = 7.9, Hz, 1H), 7.48-7.37 (m, 7H), 7.25-7.03 (m, 13H), 6.93-6.69 (m, 2H), 6.48 (d, J = 7.9 Hz, 1H), 4.07-3.98 (m, 1H), 3.97-3.90 (m, 1H), 3.88-3.77 (m, 1H), 2.38 (s, 3H), 1.27 (s, 9H). 13C{1H} NMR (150 MHz, CDCl3) δ160.3, 157.9, 138.3, 136.8, 134.8, 133.13, 133.11, 131.6, 131.3, 130.1, 128.9, 128.2, 127.7, 127.6, 126.4, 125.0, 121.1, 120.5, 57.1, 35.9, 29.8, 27.4, 21.1. 31P {1H} NMR (162 MHz, CDCl3) δ 42.2 (s, PPh3). IR (cm−1): ν3053, 2950, 2869, 1739, 1548, 1524, 1511, 1490, 1480, 1426, 1374, 1363, 1296, 1084, 833, 779, 749, 699, 685, 524, 510, 500.HRMS (ESI-TOF) m/z: [M – 2Cl-]2+calcd for C42H41N4PRu 367.1051, found 367.1057.
Example IV
The pincerlike ruthenium compound containing the asymmetric NNN ' of pyridine-pyridine-imidazoline of the present embodiment the preparation method is as follows:
(1) (S) -6- (4- isopropyl -1- (p-methylphenyl) -4,5- dihydro -1HImidazoles -2- base) -2,2'- bipyridyl preparation: 2,2- bipyridyl -6- carboxylic acids (10mmol) back flow reaction 8h in thionyl chloride solution (5 mL), revolving remove excessive sulfurous Acyl chlorides give light yellow oil is dissolved in anhydrous methylene chloride solution, under condition of ice bath, is added dropwise into dissolved with L- figured silk fabrics Ammonia alcohol (11mmol, 1.13 g) and in the anhydrous methylene chloride solution of triethylamine (30mmol, 4.2 mL), after being added dropwise, Reaction is stayed overnight at room temperature.After reaction, reactant is spin-dried for, ethyl acetate is added, insoluble matter is filtered to remove, after filtrate is spin-dried for It continuously adding and reacts 8h under thionyl chloride (5 mL) reflux state, revolving removes excessive thionyl chloride and obtains rufous grease, It is dissolved in anhydrous methylene chloride solution, under condition of ice bath, is added dropwise into (11mmol, 1.2 g) dissolved with para-totuidine In the anhydrous methylene chloride solution of triethylamine (60mmol, 8 mL), after being stirred overnight at room temperature, 10% sodium hydroxide is added Aqueous solution (35 mL), room temperature continue to stir 8-12h, after, liquid separation, water phase is extracted with dichloromethane 3 times, merge organic phase, It is dry that anhydrous magnesium sulfate is added, filters, is spin-dried for, column chromatography for separation (eluant, eluent ratio PE/EA=3/1 ~ 1/10) obtains accordingly NNN ' ligand.Brown solid;Yield: 50%;Fusing point: 82-84oC。1H NMR (400 MHz, CDCl3) δ 8.58 (d, J = 5.1 Hz, 1H), 8.33 (d, J = 7.5 Hz, 1H), 7.94 (d, J = 7.5, Hz, 1H), 7.84 (t, J = 8.0 Hz, 1H), 7.54 (ddd, J = 7.7, 7.7, 1.8 Hz, 1H), 7.40 (d, J = 8.0 Hz, 1H), 7.21 (ddd, J = 7.5, 4.9, 1.2 Hz, 1H), 6.99 (d, J = 8.0 Hz, 2H), 6.80 (d,J = 8.0 Hz, 2H), 4.20-4.07 (m, 2H), 3.75-3.65 (m, 1H), 2.26 (s, 3H), 2.01- 1.92 (m, 1H), 1.10 (d, J = 6.9 Hz, 3H), 1.00 (d, J = 6.9 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3 ) δ 160.3, 155.6, 154.9, 149.4, 148.8, 141.4, 137.4, 136.5, 133.3, 129.1, 124.1, 123.7, 123.3, 121.5, 121.4, 70.6, 56.9, 33.2, 20.9, 19.1, 18.1. IR(cm-1): 2956, 2870, 1590, 1561, 1514, 1462, 1432, 1390, 1267, 1161, 1145, 1046, 992, 819, 786, 751, 715, 635, 566. HRMS (ESI-TOF) m/z: [M + H]+calcd for C23H25N4 357.2074, found 357.2078.
(2) (S) -6- (4- (isopropyl) -1- (p-methylphenyl) -4,5- dihydro -1HImidazoles -2- base) -2,2'- bipyridyl triphen The preparation of base phosphine dichloride ruthenium: be added in the Shrek bottle equipped with 100 mL for being stirred at reflux device (S) -6- (4- (isopropyl Base) -1- (p-methylphenyl) -4,5- dihydro -1HImidazoles -2- base) -2,2'- bipyridyl (0.4mmol, 142mg), three (triphenyls Phosphine) ruthenous chloride (0.4mmol, 383mg) and 30 mL toluene, 3 h of back flow reaction, after reaction, cooling under a nitrogen atmosphere Solid is precipitated, filters, is washed with ether to get product (220 mg) is arrived.Violet solid, yield: 70%;Fusing point: > 300oC。1H NMR (600 MHz, CDCl3) δ 9.40-9.34 (m, 1H), 7.71 (d, J = 8.0 Hz, 1H), 7.52 (d,J = 8.0 Hz, 1H), 7.48-7.39 (m, 7H), 7.37-7.29 (m, 1H), 7.21-7.12 (m, 5H), 7.12-7.06 (m, 6H), 7.01 (t, J = 8.0 Hz, 1H), 6.94-6.86 (m, 2H), 6.33 (d, J = 8.0 Hz, 1H), 4.35-4.20 (m, 1H), 4.09-3.93 (m, 2H), 3.50-3.33 (m, 1H), 2.37(s, 3H), 1.14 (d, J = 6.3 Hz, 3H), 0.95 (d, J = 6.3 Hz, 3H). 13C{1H} NMR (150 MHz, CDCl3) δ 160.7, 158.1, 153.6, 139.4, 137.2, 134.6, 132.9, 132.8, 132.3, 132.1, 130.2, 128.9, 128.2, 127.8, 127.7, 126.7, 126.1, 124.2, 121.0, 120.1, 55.5, 29.2, 21.1, 20.3, 15.9. 31P{1H} NMR (162 MHz, CDCl3) δ 42.5 (s, PPh3). IR (cm−1): ν3049, 2963, 2838, 2860, 1552, 1527, 1509, 1485, 1433, 1423, 1373, 1284, 1155, 1087, 1037, 838, 779, 747, 698, 523, 510, 500.HRMS (ESI-TOF) m/z: [M – 2Cl-]2+calcd for C41H39N4PRu 360.0973, found 360.0980.
Embodiment five
The pincerlike ruthenium compound containing the asymmetric NNN ' of pyridine-pyridine-imidazoline of the present embodiment the preparation method is as follows:
(1) (S) -6- (4- benzyl -1- (p-methylphenyl) -4,5- dihydro -1HImidazoles -2- base) -2,2'- bipyridyl preparation: 2, 2- bipyridyl -6- carboxylic acid (10mmol) back flow reaction 8h in thionyl chloride solution (5 mL), revolving remove excessive thionyl Chlorine give light yellow oil is dissolved in anhydrous methylene chloride solution, under condition of ice bath, is added dropwise into dissolved with L- phenylpropyl alcohol Ammonia alcohol (11mmol, 1.82 g) and in the anhydrous methylene chloride solution of triethylamine (30mmol, 4.2 mL), after being added dropwise, Reaction is stayed overnight at room temperature.After reaction, reactant is spin-dried for, ethyl acetate is added, insoluble matter is filtered to remove, after filtrate is spin-dried for It continuously adding and reacts 8h under thionyl chloride (5 mL) reflux state, revolving removes excessive thionyl chloride and obtains rufous grease, It is dissolved in anhydrous methylene chloride solution, under condition of ice bath, is added dropwise into (11mmol, 1.2 g) dissolved with para-totuidine In the anhydrous methylene chloride solution of triethylamine (60mmol, 8 mL), after room temperature overtime work overnight, 10% sodium hydroxide is added Aqueous solution (35 mL), room temperature continue to stir 8-12h, after, liquid separation, water phase is extracted with dichloromethane 3 times, merge organic phase, It is dry that anhydrous magnesium sulfate is added, filters, is spin-dried for, column chromatography for separation (eluant, eluent ratio PE/EA=3/1 ~ 1/10) obtains accordingly NNN ' ligand.Brown solid;Yield 56%;Fusing point: 109-111oC。1H NMR (400 MHz, CDCl3) δ 8.58 (d, J= 4.7 Hz, 1H), 8.35 (d, J = 8.0 Hz, 1H), 7.93 (d, J = 7.7, Hz, 1H), 7.84 (t, J = 7.7 Hz, 1H), 7.53 (ddd, J = 7.7, 7.7, 1.8 Hz, 1H), 7.38 (d, J = 8.0 Hz, 1H), 7.32-7.26 (m, 4H), 7.23-7.16 (m, 2H), 6.96 (d, J = 8.0 Hz, 2H), 6.67 (d,J = 8.0 Hz, 2H), 4.67-4.57 (m, 1H), 4.07 (t, J = 9.5 Hz, 1H), 3.76 (dd, J = 9.6, 7.4 Hz, 1H), 3.30 (dd, J = 13.6, 4.6 Hz, 1H), 2.90 (dd, J = 13.8, 9.0 Hz, 1H), 2.24 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ 160.6, 155.5, 154.9, 148.9, 148.8, 141.0, 138.3, 137.5, 136.6, 133.6, 129.5, 129.1, 128.4, 126.4, 124.2, 123.7, 123.5, 121.6, 121.5, 65.5, 58.7, 42.2, 20.8. IR(cm-1): 3063, 3058, 2920, 2861, 1591, 1562, 1514, 1473, 1432, 1388, 1324, 1281, 1261, 1158, 1095, 1071, 992, 820, 786, 750, 728, 696, 635, 620, 599, 554, 513, 498, 465. HRMS (ESI-TOF) m/z: [M + H]+calcd for C27H25N4 405.2074, found 405.2078.
(2) (S) -6- (4- (benzyl) -1- (p-methylphenyl) -4,5- dihydro -1HImidazoles -2- base) -2,2'- bipyridyl triphenyl The preparation of phosphine dichloride ruthenium: be added in the Shrek bottle equipped with 100 mL for being stirred at reflux device (S) -6- (4- (benzyl) -1- (p-methylphenyl) -4,5- dihydro -1HImidazoles -2- base) -2,2'- bipyridyl (0.4mmol, 162mg), three (triphenylphosphine) dichloros Change ruthenium (0.4mmol, 383mg) and 30 mL toluene, under a nitrogen atmosphere 3 h of back flow reaction, it is after reaction, cooling to be precipitated admittedly Body filters, and is washed with ether to get product (220 mg) is arrived.Violet solid, yield: 66%;Fusing point: > 300oC。1H NMR (400 MHz, CDCl3) δ 9.33 (d, J = 5.3Hz, 1H), 7.77 (d, J = 7.8 Hz, 1H), 7.57- 7.49 (m, 2H), 7.48-7.42 (m, 6H), 7.39 (d, J = 7.4 Hz, 2H), 7.31 (t, J = 7.4 Hz, 2H), 7.23-7.16 (m, 5H), 7.14-7.08 (m, 8H), 6.98 (d, J = 7.7 Hz, 1H), 6.90-6.81 (m, 2H), 6.35 (d, J = 7.7 Hz, 1H), 4.84-4.75 (m, 1H), 4.57-4.45 (m, 1H), 3.85-3.73 (m, 2H), 3.12-3.01 (m, 1H), 2.35 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ 163.3, 161.1, 158.2, 153.9, 153.4, 139.3, 139.2, 137.3, 134.6, 133.1, 133.0, 132.7, 132.3, 130.2, 129.4, 129.0, 128.5, 127.8, 127.7, 126.3, 126.1, 125,8, 124.2, 121.5, 120.4, 67.1, 61.3, 41.6, 21.1. 31P{1H} NMR (162 MHz, CDCl3) δ 43.2 (s, PPh3). IR (cm−1): ν3054, 2861, 1603, 1551, 1525, 1511, 1482, 1430, 1374, 1293, 1157, 1091, 1039, 827, 777, 754, 744, 697, 527, 514, 496. HRMS (ESI-TOF) m/z: [M – 2Cl]2+calcd for C45H39N4PRu 384.0973, found 384.0987.
Basic principles and main features and advantages of the present invention of the invention have been shown and described above.The technology people of the industry Member is it should be appreciated that the present invention is not limited to the above embodiments, and the above embodiments and description only describe this hairs Bright principle, without departing from the spirit and scope of the present invention, various changes and improvements may be made to the invention, these variations It all fall within the protetion scope of the claimed invention with improvement.The claimed scope of the invention is by appended claims and its waits Effect object defines.

Claims (9)

1. the pincerlike ruthenium compound of one kind asymmetric NNN ' containing pyridine-pyridine-imidazoline, it is characterised in that: the pincer ruthenium chemical combination The structural formula of object is as follows:,
Wherein R1For C1-C15Alkyl or aryl, R2For aryl.
2. the preparation method of the pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline according to claim 1, Characterized by the following steps:
(1) 2,2- bipyridyl is passed through into hydrogen peroxide oxidation, itrile group, hydrolysis obtains 2,2- bipyridyl -6- carboxylic acid;
(2) 2,2- bipyridyl -6- carboxylic acid is flowed back in thionyl chloride, then boils off excessive thionyl chloride, ice bath instills hand Property amino alcohol anhydrous methylene chloride solution in, after being added dropwise, reaction overnight, be then spin-dried for obtaining amide compound;
(3) thionyl chloride is added into amide compound and continues back flow reaction, then boil off excessive thionyl chloride, be added anhydrous Methylene chloride and triethylamine, then aromatic amine is added dropwise in ice bath, is stirred overnight at room temperature, is eventually adding the aqueous solution of sodium hydroxide, after It is continuous to be stirred overnight, it extracts, dry, concentration, thin-layer chromatography obtains asymmetric pincer ligand;
(4) asymmetric pincer ligand and RuCl2(PPh3)3It reacts in reflux in toluene, cools down after reaction, be directly precipitated solid Body is washed with ether to get target compound is arrived.
3. the preparation method of the pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline according to claim 2, It is characterized by: the molar ratio of 2,2- bipyridyl -6- carboxylic acid and thionyl chloride is 1:(7-21 in the step (2)), 2,2- connection Pyridine -6- carboxylic acid back flow reaction 8-12h in thionyl chloride, mole of 2, the 2- bipyridyl -6- carboxylic acid and chiral amino alcohol Than for 1:(1-2).
4. the method for the pincerlike ruthenium compound of synthesis according to claim 2 asymmetric NNN ' containing pyridine-pyridine-imidazoline, It is characterized by: the molar ratio of amide compound and aromatic amine is 1:(1-2 in the step (3)).
5. the preparation method of the pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline according to claim 2, It is characterized by: amide compound return time in thionyl chloride is 8-12h in the step (3).
6. the preparation method of the pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline according to claim 2, It is characterized by: the molar ratio of amide compound and thionyl chloride is 1:(7-21 in the step (3)), amide compound and three Ethamine, sodium hydroxide molar ratio be 1:6:(8-12).
7. the preparation method of the pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline according to claim 2, It is characterized by: room temperature is stirred to react 8-16h after the pure and mild aromatic amine of chiral amino is added dropwise in ice bath.
8. the preparation method of the pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline according to claim 2, It is characterized by: the aqueous solution of sodium hydroxide is added in the step (3), continue to be stirred to react 8-12h, sodium hydroxide it is water-soluble The mass concentration of liquid is 10%.
9. the preparation method of the pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline according to claim 2, It is characterized by: in the step (4), asymmetric pincer ligand and RuCl2(PPh3)3The ratio between the amount of substance be 1:(1-2), Reflux time is 2-5 hours.
CN201910323217.9A 2019-04-22 2019-04-22 Pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline and preparation method thereof Pending CN109970814A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910323217.9A CN109970814A (en) 2019-04-22 2019-04-22 Pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910323217.9A CN109970814A (en) 2019-04-22 2019-04-22 Pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline and preparation method thereof

Publications (1)

Publication Number Publication Date
CN109970814A true CN109970814A (en) 2019-07-05

Family

ID=67085644

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910323217.9A Pending CN109970814A (en) 2019-04-22 2019-04-22 Pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline and preparation method thereof

Country Status (1)

Country Link
CN (1) CN109970814A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110818689A (en) * 2019-10-31 2020-02-21 华侨大学 Pincer-shaped polypyridine-polypyrrole silver cluster compound containing five coordination sites as well as preparation method and application thereof
CN114591509A (en) * 2022-03-16 2022-06-07 华中科技大学同济医学院附属协和医院 Metal organic framework material with antioxidant activity

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110818689A (en) * 2019-10-31 2020-02-21 华侨大学 Pincer-shaped polypyridine-polypyrrole silver cluster compound containing five coordination sites as well as preparation method and application thereof
CN110818689B (en) * 2019-10-31 2022-03-25 华侨大学 Pincer-shaped polypyridine-polypyrrole silver cluster compound containing five coordination sites as well as preparation method and application thereof
CN114591509A (en) * 2022-03-16 2022-06-07 华中科技大学同济医学院附属协和医院 Metal organic framework material with antioxidant activity
CN114591509B (en) * 2022-03-16 2023-02-17 华中科技大学同济医学院附属协和医院 Metal organic framework material with antioxidant activity

Similar Documents

Publication Publication Date Title
CN109970814A (en) Pincerlike ruthenium compound of the asymmetric NNN ' containing pyridine-pyridine-imidazoline and preparation method thereof
CN102584795A (en) Preparing method of crizotinib
CN105061431A (en) 6-N-(2-(methylthio)ethyl)-2-((3,3,3-trifluoropropyl)sulfo)-9H-purine, and preparation method and application thereof
CN105473544A (en) Compounds of '3-(5-sustituted oxy-2,4-dinitro-phenyl)-2-oxo-propionic acid ester', process and applications thereof
CN101563312A (en) Process for producing intermediate of asenapine synthesis
CN113683651A (en) Preparation method of GalNAc intermediate
CN107810189A (en) Method for preparing nitrogen mustard derivatives
CN109956901B (en) Preparation method of isoquinolone compound
JPH03209348A (en) Production of eneyne derivative
CN103360410A (en) Preparation method of ofloxacin
CN109516919A (en) A kind of preparation method of three (2- amino-ethyl) amine
CN109400528A (en) A kind of synthetic method for winning beauty
CN105153013B (en) The synthetic method of the ketone of 6 bromine isoindoline 1
CN105777584A (en) Method for preparing alanine derivative
CN100427460C (en) Method for synthesis of L-norvaline
CN106588739B (en) A kind of trans- 3- hydroxy-L-proline preparation method
CN103517897A (en) Synthesis of cyclopentaquinazolines
CN106632594B (en) Method for synthesizing pidotimod
CN105745191A (en) Method for preparing silodosin and intermediate thereof
CN105461662A (en) Synthetic method for chiral epoxy compound of anti-HIV drug intermediate
CN100522965C (en) 8-arylamine-3H-imidazole [4,5-g] quinazoline derivatives and its solid phase synthesis method
CN107674037A (en) The method of one kind 5 methyl 2 (triazoles of 2H 1,2,3) benzoic acid of synthesis
CN105037239B (en) A kind of preparation method of the acetic acid of 4 chloro-indole 3
CN107043355B (en) A kind of hydrochloric acid Emedastine midbody compound and preparation method thereof
CN109734667A (en) A kind of polysubstituted imidazolium compounds and its synthetic method and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190705

RJ01 Rejection of invention patent application after publication